RUBICON RESEARCH (RUBICON) Share Price falls in second straight session
- October 8, 2026
- Posted by: Kunal Singla
- Category: News
RUBICON RESEARCH Share Price is lower in its second straight session, with the latest traded price at Rs 1,400.8 after a 5.95% cumulative fall across the streak from Rs 1,489.35. Univest figures confirm the price action, but they do not point to a specific company trigger.
RUBICON RESEARCH Share Price now carries a market capitalisation of Rs 24,654.57 crore, which places the company in the Large Cap category. For a reader tracking RUBICON RESEARCH Share Price Fall Streak, the key takeaway is that two consecutive lower sessions matter more than a single-day dip because the move now shows a pattern, not only an intraday swing.
RUBICON RESEARCH (RUBICON) Share Price Fall Streak: Consecutive Decline Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,400.8 |
| Previous Close | Rs 1,450.25 |
| Today's Move | -Rs 49.45 (-3.41%) |
| Open | Rs 1,430.15 |
| High | Rs 1,441.3 |
| Low | Rs 1,398.05 |
| Market Capitalisation | Rs 24,654.57 crore |
RUBICON RESEARCH Share Price traded at Rs 1,400.8, down Rs 49.45 or 3.41% from the previous close of Rs 1,450.25. The stock opened at Rs 1,430.15, touched a high of Rs 1,441.3 and a low of Rs 1,398.05, before the latest traded price settled near the lower end of the range. That range shows the session stayed confined within a narrow band relative to the previous close, but the day still finished with a clear decline in RUBICON RESEARCH Share Price.
The market capitalisation stood at Rs 24,654.57 crore, and the stock remained in the Large Cap bracket. For investors following RUBICON RESEARCH Share Price Fall Streak, the important point is that the latest move extends the lower-price pattern rather than reversing it. The streak also matters because the cumulative decline of 5.95% from Rs 1,489.35 is now larger than the current day’s fall alone. That makes RUBICON RESEARCH Share Price a stock to read through the lens of repeated weakness rather than a one-off move, before moving to valuation and financial context.
What the Consecutive Declines Show
RUBICON RESEARCH Share Price Fall Streak now reflects a second straight session of decline, and that changes the way the price action should be read. A two-session pattern tells readers that the stock has remained under pressure across more than one trading window, with the cumulative move now at -5.95% from the stated streak start price of Rs 1,489.35. The latest day accounts for Rs 49.45 of the fall, while the overall streak covers a larger adjustment in the share price.
For RUBICON RESEARCH Share Price, the distinction between the latest session and the two-session run is important. A single decline can be isolated; two consecutive lower sessions create a short streak that deserves separate attention. Univest figures confirm the price action, but they do not point to a specific company trigger. That makes the streak itself the verified story, while the next sections help place RUBICON RESEARCH Share Price within valuation, sector and peer context.
RUBICON RESEARCH (RUBICON) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 24,654.57 crore |
| P/E Ratio | 83.3x |
| P/B Ratio | 17.88x |
| ROE | 27.84% |
| ROCE | 29.22% |
| EPS | Rs 17.41 |
| Book Value Per Share | Rs 81.09 |
| Dividend Yield | 0.1% |
RUBICON RESEARCH (RUBICON) fundamental metrics show P/E 83.3x, P/B 17.88x, ROE 27.84%, ROCE 29.22%. Taken on their own, these numbers offer context rather than a trading signal.
RUBICON RESEARCH has a market capitalisation of Rs 24,654.57 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 83.3x, P/B at 17.88x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 27.84% and ROCE of 29.22%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 17.41, book value per share of Rs 81.09, dividend yield of 0.1%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.23x, median ROE of 11.33%, median ROCE of 13.25%. They set out the fundamental picture and are not a rating on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 83.3x |
| Benchmark Median P/E | 31.23x |
| Benchmark Average P/E | 45.39x |
| Benchmark P/E Range | 3.4x to 616.23x |
| Company P/B Ratio | 17.88x |
| Benchmark Median P/B | 2.71x |
| Benchmark Average P/B | 4.05x |
| Company ROE | 27.84% |
| Benchmark Median ROE | 11.33% |
| Benchmark Average ROE | 10.08% |
| Company ROCE | 29.22% |
| Benchmark Median ROCE | 13.25% |
| Benchmark Average ROCE | 12.99% |
| Company Market Capitalisation | Rs 24,654.57 crore |
| Benchmark Median Market Cap | Rs 771.43 crore |
| Benchmark Average Market Cap | Rs 13,461.56 crore |
RUBICON RESEARCH (RUBICON) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
RUBICON RESEARCH (RUBICON) has a P/E ratio of 83.3x, which is above the benchmark median of 31.23x, a difference of +166.73%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
RUBICON RESEARCH (RUBICON) has a ROE of 27.84%, which is above the benchmark median of 11.33%, a difference of +145.72%. RUBICON RESEARCH (RUBICON) has a ROCE of 29.22%, which is above the benchmark median of 13.25%, a difference of +120.53%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,18,683.95 | 34.61 | 4.84 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,41,310.94 | 83.04 | 13.75 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,73,078.79 | 78.96 | 19.19 | 26.76 | 19.27 |
| Laurus Labs | LAURUSLABS | 1,11,433.99 | 99.43 | 19.28 | 18.31 | 18.2 |
| Zydus Lifesciences | ZYDUSLIFE | 1,11,022.18 | 24.7 | 4.13 | 19.69 | 21.39 |
RUBICON RESEARCH (RUBICON) has a P/E ratio of 83.3x compared with the displayed peer median of 78.96x. The comparison is relative and should not be read as a recommendation. Its ROE of 27.84% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 29.22% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. RUBICON RESEARCH (RUBICON) has a market capitalisation of Rs 24,654.57 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching RUBICON RESEARCH
- RUBICON RESEARCH Share Price is in a second straight session of decline, which makes the streak itself the main price signal.
- The latest traded price of Rs 1,400.8 remains below the previous close of Rs 1,450.25, keeping the share price under near-term pressure.
- RUBICON RESEARCH Share Price Fall Streak now totals -5.95% from Rs 1,489.35, so the cumulative move is larger than the latest daily fall.
- The company’s P/E of 83.3 and P/B of 17.88 remain well above the Healthcare benchmark medians, which keeps valuation in focus.
- ROE of 27.84% and ROCE of 29.22% are strong versus the benchmark, so the streak is occurring in a premium-valued earnings profile.
About RUBICON RESEARCH
RUBICON RESEARCH operates in Healthcare and the Pharmaceuticals & Drugs industry. For readers tracking RUBICON RESEARCH Share Price Fall Streak, the key business context is that the company sits in a sector where valuation often reflects both earnings quality and return ratios. Its current market capitalisation places it in the Large Cap category, and that size matters when comparing the stock’s move with peers and the wider benchmark. RUBICON RESEARCH Share Price is therefore being read not just as a price chart event, but as a shift in a premium Healthcare valuation.
Track RUBICON RESEARCH Share Price on Univest
Use RUBICON RESEARCH (RUBICON) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
RUBICON RESEARCH Share Price can be followed on Univest for live price updates, key valuation ratios, 52-week levels and market insights. Investors using Univest can review the same share price context alongside fundamental ratios, sector positioning and peer comparison in one place. For a stock in a fall streak, that combination helps keep the discussion tied to verified price action and the company’s financial profile.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why is RUBICON RESEARCH Share Price falling today?
Ans. RUBICON RESEARCH Share Price is lower in a second straight session, with the latest traded price at Rs 1,400.8. Univest figures confirm the price action, but they do not point to a specific company trigger.
What is RUBICON RESEARCH Share Price today?
Ans. RUBICON RESEARCH Share Price is trading at Rs 1,400.8 as of 22 October 2026 at 9:53:17 AM IST. It is down Rs 49.45, or 3.41%, from the previous close of Rs 1,450.25.
How much has RUBICON RESEARCH Share Price fallen in the streak?
Ans. RUBICON RESEARCH Share Price Fall Streak covers a cumulative decline of 5.95% from the streak start base price of Rs 1,489.35. The latest session adds another 3.41% fall to that run.
What is the market capitalisation of RUBICON RESEARCH ?
Ans. RUBICON RESEARCH has a market capitalisation of Rs 24,654.57 crore. That places it in the Large Cap category and above the benchmark median market capitalisation for the same industry.
How does RUBICON RESEARCH compare on valuation?
Ans. RUBICON RESEARCH trades at a P/E of 83.3 and a P/B of 17.88. Both are above the Healthcare benchmark medians of 31.23 and 2.71, showing a premium valuation profile.
How do ROE and ROCE look for RUBICON RESEARCH ?
Ans. RUBICON RESEARCH reports ROE of 27.84% and ROCE of 29.22%. Both are higher than the benchmark medians in the same industry, which gives the share price streak a strong profitability backdrop.
What does EPS and book value show for RUBICON RESEARCH Share Price?
Ans. EPS is Rs 17.41 and book value is Rs 81.09. EPS indicates earnings attributable to each share, while book value per share shows the accounting net worth behind each share at the current RUBICON RESEARCH Share Price.
How does RUBICON RESEARCH compare with peers?
Ans. RUBICON RESEARCH has a P/E of 83.3, higher than Sun Pharmaceutical Industries, Zydus Lifesciences and Cipla, and close to Divi’s Laboratories Its ROE and ROCE are also stronger than those peers shown.
Should investors track RUBICON RESEARCH Share Price on Univest?
Ans. Yes. Univest tracks RUBICON RESEARCH Share Price alongside valuation ratios, sector benchmarks and 52-week levels. That helps investors monitor the streak in context without relying only on the latest daily move.
